Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

Wenhui Xie; Yu Wang; Zhuoli Zhang

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

【24h】

Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

机译：羟基氯喹减少了风湿病患者Covid-19的风险：神话或现实？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2021年第1期|共1页
作者
Wenhui Xie; Yu Wang; Zhuoli Zhang;
展开▼
作者单位

Department of Rheumatology and Clinical Immunology;

Department of Rheumatology and Clinical Immunology;

Department of Rheumatology and Clinical Immunology;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
hydroxychloroquine; autoimmune diseases; outcome assessment; health care;

机译：羟基氯喹;自身免疫性疾病;结果评估;医疗保健;

相似文献

外文文献
中文文献
专利

1. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: ‘Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?’ by Xie et al [J] . Carmen Magdalena Gamboa-Alonso, Gabriel Figueroa-Parra, Dionicio Angel Galarza-Delgado Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2021,第1期

机译：仍然早期为有风湿病患者的Covid-19抗疟疾药物的明确作用。回应：'羟基氯喹减少了风湿病患者Covid-19的风险：神话或现实？'通过谢等人
2. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit [J] . Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2020,第6期

机译：羟基氯喹可以保护患者免受Covid-19的风湿性疾病吗？回应：'羟基氯喹是否防止了Covid-19的传输？' 通过Holdwein和Calado和'SLE，羟基氯喹，没有Covid-19的SLE患者：评论'由Joob和Wiwanitkit
3. A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquine's Prophylactic Effect Against Infection With SARS-CoV-2 [J] . Musca Serban C. Frontiers in Medicine . 2020,第2期

机译：一种简单的贝叶斯方法，用于评估来自慢性羟基氯喹药物的风湿性疾病的数据是否从Covid-19爆发之前达到慢性羟基氯喹药物，可以与SARS-COV-2的羟基氯喹对羟基氯喹的预防效果交谈
4. Using mobile technologies with psychiatric patients: Assessing the potential to reduce risk of developing diseases related to inactivity [C] . Anna Holubová, Jakub Schlenker, Vladimír Socha, IEEE International Symposium on Applied Machine Intelligence and Informatics . 2017

机译：使用具有精神科患者的移动技术：评估降低与不活动有关的疾病风险的潜力
5. Socioeconomic Status, Benzathine Penicillin Prophylaxis, and Clinical Outcomes in Patients with Rheumatic Heart Disease [D] . ?Yilgwan, Christopher Sabo 2020

机译：社会经济地位，苯甲丝青霉素预防，以及风湿性心脏病患者的临床结果
6. A Simple Bayesian Method for Evaluating Whether Data From Patients With Rheumatic Diseases Who Have Been Under Chronic Hydroxychloroquine Medication Since Before the COVID-19 Outbreak Can Speak to Hydroxychloroquines Prophylactic Effect Against Infection With SARS-CoV-2 [O] . Serban C. Musca 2020

机译：一种简单的贝叶斯方法用于评估来自慢性羟基氯喹药物的风湿性疾病的数据是否从Covid-19爆发之前达到慢性羟基氯喹药物可以与SARS-COV-2的羟基氯喹对羟基氯喹的预防效果交谈
7. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: ‘Does hydroxychloroquine prevent the transmission of COVID-19?’ by Heldwein and Calado and ‘SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment’ by Joob and Wiwanitkit [O] . Sara Monti, Carlomaurizio Montecucco 2020

机译：羟基氯喹可以保护患者免受Covid-19的风湿性疾病吗？回应：'羟基氯喹是否通过Holdwein和Calado和'SLE，羟基氯喹和没有Covid-19的SLE，羟基氯喹和No SLE-19：评论'评论'，通过joob和wiwanitkit来传播Covid-19？'
8. Risk Indicators in Coronary Cardiac Disease and Occlusive Disease of the Peripheral Arteries: Comparative Coronary and Peripheral Angiography - Total Angiography - in 160 Patients [R] . Roth, H. 1982

机译：冠状动脉心脏病和外周动脉闭塞性疾病的风险指标：比较冠状动脉和外周血管造影 - 总血管造影 - 160名患者

Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?

著录项

相似文献

相关主题

期刊订阅